VCID: 421426
Profile

Corporate information

Investment activity status
Active investor

Selected investments

Country Date Notes
Avelas Biosciences Inc
Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons. 		United States 18 Aug 2016 Series C
Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.